<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 54-year-old man with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus (HCV) developed quadrihemianopsia caused by lacunar <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Extensive evaluation revealed high titers of anticardiolipin antibodies (ACA) </plain></SENT>
<SENT sid="2" pm="."><plain>Following interferon treatment (6 x 10(6), three times a week for 2 months and 3 x 10(6) for another 7 months), liver transaminase levels decreased to <z:mpath ids='MPATH_458'>normal</z:mpath>, HCV <z:chebi fb="40" ids="33697">RNA</z:chebi> in blood was no longer detectable, concomitantly with the disappearance of the ACA </plain></SENT>
<SENT sid="3" pm="."><plain>The patient remained clinically stable without evidence for either HCV activity (<z:chebi fb="40" ids="33697">RNA</z:chebi>) or ACA or further <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> </plain></SENT>
</text></document>